In last trading session, Senti Biosciences Inc (NASDAQ:SNTI) saw 64470.0 shares changing hands with its beta currently measuring 2.42. Company’s recent per share price level of $3.90 trading at -$0.53 or -11.96% at ring of the bell on the day assigns it a market valuation of $17.90M. That closing price of SNTI’s stock is at a discount of -334.36% from its 52-week high price of $16.94 and is indicating a premium of 61.03% from its 52-week low price of $1.52. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 87000.0 shares which gives us an average trading volume of 2.30 million if we extend that period to 3-months.
Senti Biosciences Inc (NASDAQ:SNTI) trade information
Upright in the red during last session for losing -11.96%, in the last five days SNTI remained trading in the green while hitting it’s week-highest on Monday, 01/06/25 when the stock touched $3.90 price level, adding 18.24% to its value on the day. Senti Biosciences Inc’s shares saw a change of 11.11% in year-to-date performance and have moved 11.11% in past 5-day. Senti Biosciences Inc (NASDAQ:SNTI) showed a performance of -29.09% in past 30-days. Number of shares sold short was 65095.0 shares which calculate 3.27 days to cover the short interests.
Senti Biosciences Inc (SNTI) estimates and forecasts
Statistics highlight that Senti Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 25.81% of value to its shares in past 6 months, showing an annual growth rate of 22.66% while that of industry is 17.00. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
In 2025, company’s earnings growth rate is likely to be around 9.13% while estimates for its earnings growth in next 5 years are of 17.99%.
Senti Biosciences Inc (NASDAQ:SNTI)’s Major holders
Insiders are in possession of 21.00% of company’s total shares while institution are holding 23.33 percent of that, with stock having share float percentage of 29.53%. Investors also watch the number of corporate investors in a company very closely, which is 23.33% institutions for Senti Biosciences Inc that are currently holding shares of the company. NEA MANAGEMENT COMPANY, LLC is the top institutional holder at SNTI for having 4.43 million shares of worth $1.22 million. And as of 2024-06-30, it was holding 9.6834 of the company’s outstanding shares.
The second largest institutional holder is 8VC GP I, LLC, which was holding about 2.54 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.5516 of outstanding shares, having a total worth of $7.0 million.
